Table 1. Baseline characteristics of the study population.
| Total (n=379) | |
|---|---|
| Age (years) | 67.2±12.6 |
| Sex, male | 230 (59.9) |
| Body mass index (kg/m2) | 23.7±3.1 |
| Stroke characteristics | |
| Prestroke mRS score of 0 or 1 | 365 (96.3) |
| NIHSS score at admission | 5.0 [2.0.11.0] |
| Onset to admission time (min) | 482 [95.1188] |
| TOAST classification | |
| Large-artery atherosclerosis | 123 (32.5) |
| Small-vessel occlusion | 83 (21.9) |
| Cardioembolism | 108 (28.5) |
| Stroke of other determined etiology | 48 (12.6) |
| Stroke of undetermined etiology | 17 (4.5) |
| Risk factor | |
| Hypertension | 233 (61.5) |
| Diabetes mellitus | 119 (31.4) |
| Hyperlipidemia | 134 (35.4) |
| Atrial fibrillation | 101 (26.6) |
| Smoking | 131 (34.6) |
| Previous stroke | 74 (19.5) |
| Systolic blood pressure (mm Hg) | 151.6±24.7 |
| Laboratory data | |
| Insulin-like growth factor-1 (ng/mL) | 116.0±54.9 |
| White blood cell count (×103/μL) | 8.39±3.01 |
| Initial glucose (mg/dL) | 152.8±63.1 |
| High-sensitivity C-reactive protein (mg/dL) | 2.74 [1.00.9.11] |
| Hemoglobin A1c (%) | 6.2±1.2 |
| Serum creatinine (mg/dL) | 0.94±0.89 |
| Low-density lipoprotein cholesterol (mg/dL) | 111.8±36.4 |
Data are mean±standard deviation, median [interquartile range], or n (%) values.
mRS: modified Rankin scale, NIHSS: National Institutes of Health Stroke Scale, TOAST: Trial of Org 10172 in Acute Stroke Treatment.